Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia.
Saved in:
| Title: | Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia. |
|---|---|
| Authors: | globenewswire |
| Source: | Marketwire (English). 09/24/2018. |
| Abstract: | Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has completed and submitted its application to INVIMA (the Colombian equivalent of... [ABSTRACT FROM PUBLISHER] |
| Database: | Newspaper Source Plus |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has completed and submitted its application to INVIMA (the Colombian equivalent of... [ABSTRACT FROM PUBLISHER] |
|---|
